Understanding how resilience affects HIV prevention among people who inject drugs in rural Ohio
Examining the mediating effect of resilience on intersectional stigma and HIV prevention among people who inject drugs in rural Appalachia Ohio
This study is looking at how people who inject drugs in rural Appalachia, Ohio, can build their strength and resilience to better handle the stigma around drug use and HIV, with the goal of helping them seek better health and reduce their risk of HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-10836658 on NIH RePORTER |
What this research studies
This research investigates the impact of resilience on the ability of people who inject drugs (PWID) in rural Appalachia, Ohio, to navigate the stigma associated with drug use and HIV. It aims to understand how these individuals can build resilience to improve their health-seeking behaviors and reduce their risk of HIV. The study will involve assessing the experiences of PWID with stigma and their coping strategies, ultimately seeking to identify ways to enhance HIV prevention efforts in these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and reside in rural areas of Appalachia, particularly in counties identified as high-risk for HIV outbreaks.
Not a fit: Patients who do not inject drugs or those living outside the targeted rural Appalachian counties may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV prevention strategies tailored for vulnerable populations, potentially reducing HIV transmission rates.
How similar studies have performed: Previous research has shown that building resilience can help at-risk populations overcome stigma and improve health outcomes, indicating a promising approach in this area.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Endres-Dighe, Stacy M. — Ohio State University
- Study coordinator: Endres-Dighe, Stacy M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.